We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
Microscopically, the lesions resembled encapsulated fatnecrosis occurring in human subcutaneous tissue.
2
Epicardial fatnecrosis is a rare cause of benign chest pain.
3
MR imaging with fat suppression technique revealed an oil-containing lesion, indicating fatnecrosis.
4
Abdominal fatnecrosis (bovine lipomatosis) was not observed in any animal.
5
It was diagnosed as omental herniation and fatnecrosis.
6
Grossly, the tumors were generally multiloculated cystic masses associated with areas of fatnecrosis and hemorrhage.
7
Pericardial fatnecrosis remains a rare clinical entity.
8
Symptomatic fatnecrosis was significantly associated with a worse cosmetic outcome, whereas asymptomatic fatnecrosis was not.
9
There were no symptomatic seromas, and one report of asymptomatic fatnecrosis seen on mammogram at 1 year.
10
Cicatricial contracture deformities in breast reconstruction can result from delayed wound healing, fatnecrosis, or chest wall radiation.
11
The incidence of both symptomatic and asymptomatic fatnecrosis is similar after conventional WBI and accelerated partial-breast HDR-BT.
12
The incidence of fatnecrosis, its impact on cosmetic outcome, accompanying radiologic features, and clinical symptoms were evaluated.
13
The corresponding rates of asymptomatic fatnecrosis were 20.0% and 20.6%.
14
Its effectiveness as treatment is due to emulsification of phospholipids and therefore, solubilization of the biological membranes with resulting fatnecrosis.
15
Conclusions: Asymptomatic fatnecrosis is a common adverse event of breast-conserving therapy, having no significant clinical relevance in the majority of the cases.
16
After corticosteroid injection 11 patients experienced a steroid flare and 2 had fatnecrosis at the site of injection.